Gene Query: GGA3

Dataset Description Geneva Score
Control of prostate tumour growth by the long non-coding RNA GHSROS 49.77
CD95/Fas ligand mRNA is toxic to cells 26.65
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 20.58
Genome wide expression change by RNF168 knocking down in MCF-7 cells 18.04
Comparison of microRNA Profiling Platforms (HTS) 13.98
Comparison of microRNA Profiling Platforms 13.98
DRB/GRO-Seq -/+ UV 13.67
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 13.57
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 12.98
Gene expression changes after LOC550643 silencing 12.87
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 12.7
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 12.69
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 12.49
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 12.47
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 11.68
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 10.8
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 10.65
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 10.48
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 10.32
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 10.17
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes [RNA-seq] 10.1
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes. 10.1
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 10.07
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 9.8
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 9.8
EWSR1 influences alternative splicing through direct and indirect mechanisms 9.75
Characterization of sperm lncRNA and its differently expression in the sperm of asthenozoospermic patients 9.63
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 9.59
IgG immunocomplexes sensitize human monocytes for inflammatory hyperactivity via transcriptomic and epigenetic reprogramming in Rheumatoid Arthritis 9.54
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 9.47
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 9.43
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 9.37
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 9.2
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 9.1
Paxillin regulates genomic networks in prostate cancer [PC3] 9.1
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 9.07
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 8.94
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 8.85
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 8.81
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 8.79
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 8.67
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 8.52
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 8.5
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 8.43
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 8.41
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 8.35
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 8.35
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 8.35
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 8.24
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 8.19
MOF acetyl transferase regulates transcription and respiration in mitochondria 8.15
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 8.08
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 8.08
The evolution of N6-methyladenosine in primates 8.04
Seletive inhibition of CDK9 in DLBCL cell lines 7.91
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 7.37
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 7.27
Chronophin regulates metabolic and transcriptomic features of glioblastoma stem-like cells 7.23
Atheroprotective flow alters EZH2/H3K27me3 dependent transcriptional profile in human endothelial cells 7.21
Genome wide expression change by RNF168 knocking down in NEC cells 7.09
Identification of global XBP1s target gene expression in human prostate cancer cells 7.08
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 7.05
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 7.01
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 6.81
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 6.8
Effect of CTCF and Rad21 knockdown on SLK cells and KSHV gene expression 6.77
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 6.73
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 6.71
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 6.69
Transcriptome sequencing of K-562 cells 6.67
SUV420H2 knockdown in PANC-1 6.66
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 6.49
Intrahepatic MAIT cell gene expression revealed by RNA-seq 6.48
Neurofibroma 6.46
Differential expression in wild-type and mutant neurofibroma and MPNST cell lines 6.46
Effect of BRCA1 overexpression on genetic expressions of cervical cancer based on next generation sequencing 6.38
Expression and functions of long noncoding RNAs during human T helper cell differentiation 6.32
shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 reveals set of genes potentially coregulated by MED25 and ETV4 6.28
Genome-wide occupancy of FLAG-MED25 and ETV4 and expression profiling of shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 6.28
RNA-seq analysis to identify the genes regulated by p53-SET interplay 6.27
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 6.25
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 6.23
Overexpression and knockdown experiment for circCSNK1G3 6.2
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 6.19
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 6.19
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 6.17
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 6.13
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 5.95
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 5.85
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 5.84
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 5.75
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 5.75
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 5.7
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 5.69
Huntingtin aggregation impairs autophagy leading to Argonaute-2 accumulation and global microRNA dysregulation 5.63
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 5.63
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 5.61
Cooperation between TLX1 and the NUP214-ABL1/STAT5 signaling in T-cell acute lymphoblastic leukemia 5.6
DART-seq: an antibody-free method for global m6A detection 5.56
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 5.53
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 5.52
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 5.5
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 5.5
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 5.5
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 5.49
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 5.47
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 5.46
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 5.46
Human neutrophil genome during PMA- and E. coli encounter-induced activation 5.44
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 5.44
Transcriptional profiles of human blood dendritic cell (DC) subsets at steady state 5.44
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 5.43
RNAseq of T-ALL upon long non coding rna purturbation 5.43
Accurate annotation of human protein-coding small open reading frames 5.42
T47D RNA-seq and ChrRNA-seq data 5.41
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 5.41
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 5.4
High-throughput sequencing of pluripotent cells 5.32
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 5.28
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 5.28
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 5.21
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 5.17
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 5.17
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 5.14
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 5.13
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 5.1
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 5.09
RNA-seq of human aneuploid cell lines with Trisomy 21 5.09
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 5.08
Functional role of CPPED1 in trophoblasts. 5.08
UBE3A-mediated regulation of imprinted genes and epigenome-wide marks in human neurons 5.07
Directed differentiation of human embryonic stem cells to corneal endothelial cell-like cells: A transcriptomic analysis 5.03
RNAseq analysis of ESRP regulated splicing events in prostate cancer 5.0
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 4.9
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 4.84
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities 4.82
Pharmacologic inhibition of STAT5 in AML 4.81
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 4.81
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 4.74
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 4.74
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors 4.74
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 4.72
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 4.72
Next Generation Sequencing Facilitates Quantitative Analysis of ALDH+ E-BCSC, CD24-CD44+ M-BCSC and Bulk tumor cell Transcriptomes from MC1 and Vari068 PDX models of TNBC 4.69
Gene expression profiling associated with knockdown of RNF20 in human normal and malignant lung epithelial cell lines 4.67
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 4.66
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 4.66
SNHG5 siRNA knock down in HCT116 cells 4.65
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] 4.62
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 4.62
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 4.62
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 4.62
mRNA expression profile of Lymphocytes 4.57
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 4.55
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 4.54
Transcriptome profiling in primary human skeletal myotubes with MondoA knockdown 4.5
MondoA Links Muscle Lipid Accumulation and Insulin Resistance Driven by Nutrient Overload 4.5
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 4.5
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 4.48
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 4.48
Knockdown of ADNP in HCT116 colon cancer cells 4.44
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 4.43
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 4.43
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 4.43
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 4.42
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 4.37
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 4.37
Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1 4.35
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 4.34
ENCODE Cold Spring Harbor Labs Long RNA-seq 4.33
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 4.31
A transcriptome-wide divergence in protein translation scales with LIN28B expression 4.31
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 4.31
RNA transcriptome analysis during HSV-1 infection 4.3
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 4.29
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 4.29
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 4.29
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 4.29
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 4.29
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 4.29
LINE-2 transposable elements are a source of functional human microRNAs and target sites 4.28
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 4.25
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 4.24
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 4.22
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 4.21
Transcriptome analysis of CNS leukemia 4.21
Error-free and error-prone DNA repair gene expression through reprogramming and passage in human iPS cells 4.18
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 4.17
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 4.17
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 4.16
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 4.15
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 4.15
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 4.14
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 4.13
Transcriptomics of human macrophages upon infection with Legionella pneumophila and two isogenic mutants, LamA and AnkH using RNA-seq 4.11
Enhancer divergence and cis-regulatory evolution in the human and chimpanzee neural crest 4.09
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 4.09
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 4.08
Mechanosensitive ion channel regulates tissue stiffening to promote glioma aggression 4.06
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 4.03
Cell responses to dysregulated VZV-induced cell-cell fusion 4.02
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 4.01
Transcriptome-wide identification of CELF2 functional targets in T cells 4.0
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 4.0
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 3.99
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 3.99
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 3.98
CRIG identifies a novel population of highly phagocytic peritoneal macrophages associated with disease severity in patients with cirrhosis and ascites 3.95
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 3.94
Salmonella activation of STAT3 signaling by SarA effector promotes intracellular replication and production of IL-10 3.93
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 3.92
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 3.92
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 3.91
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 3.89
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 3.89
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 3.88
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 3.88
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 3.84
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 3.83
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 3.82
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 3.82
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 3.8
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 3.8
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 3.79
Landscape and variation of RNA secondary structure across the human transcriptome 3.77
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 3.72
Transcriptome analysis of peripheral blood monocytes 3.7
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 3.69
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 3.67
Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor 3.6
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 3.6
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 3.6
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 3.59
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 3.59
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 3.57
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 3.55
CD1c+ dendritic cell activation by Plasmodium falciparum-infected red blood cells 3.54
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 3.53
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 3.48
Searching for target genes of miR-508/509/506/514 in HCT116 cells 3.48
Mutational landscape of splicing genes and functional consequences across 33 cancer types 3.45
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 3.45
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 3.36
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 3.36
PRDM1 inhibits proliferation of human colon cancer organoids 3.34
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 3.34
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 3.32
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 3.29
Sequence dependency and regulatory function of dimeric NOTCH1/RBPJ complexes on coding and non-coding transcription in T-lymphoblastic leukemia 3.28
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 3.23
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 3.23
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 3.21
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 3.16
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 3.15
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 3.08
Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells 3.08
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 3.03
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 2.96
mRNA recovered upon RNF219 IP. [RNA-IP] 2.94
Studying the selectivity of a targeted small molecule degrading a hypoxia-associated non-coding RNA 2.9
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 2.88
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 2.87
Gene expression in GBM with Cav3.2 inhibition 2.87
Generation and persistence of human tissue-resident memory T cells in lung transplantation 2.86
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 2.85
Functional characterization of human T cell hyporesponsiveness induced by CTLA4-Ig 2.85
Total RNA-Seq data from leukemic patients with complex structural variants 2.85
RNA sequencing of human macrophages treated with iron chelator deferiprone (DEF), with and without lipopolysaccharide (LPS) 2.85
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 2.8
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 2.8
RNA-seq of naive and primed ES cells (NHSM) 2.79
Gene expression in mature and immature human ES-derived beta cells, and sorted beta-cells from adult islets 2.75
HEXIM1 is induced by DHODH inhibition to suppress melanoma 2.74
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 2.74
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis 2.72
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 2.7
IMP3 regulated gene expression in breast cancer cells 2.7
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 2.69
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 2.69
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 2.68
Transcriptional effect of ETV1 knockdown in melanoma cells 2.66
UV_24h_GRO-Seq 2.66
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 2.65
TT-Seq captures the human transient transcriptome 2.65
Clinker: visualizing fusion genes detected in RNA-seq data 2.64
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 2.62
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 2.62
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 2.61
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 2.59
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 2.59
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 2.56
RNA-Seq and expression data from human adipose tissue 2.56
Molecular pathogenesis of human prostate basal cell hyperplasia reveals a keratinocyte metaplasia 2.56
Homolog-selective degradation as a strategy to probe the function of CDK6 in AML 2.55
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 2.53
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 2.53
RING-finger protein 6 amplification activates JAK/STAT3 pathway by modifying SHP-1 ubiquitylation and associates with poor outcome in colorectal cancer 2.51
Ectoderm specification of H1 human embryonic stem cells 2.51
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 2.48
Transcriptional dependencies in diffuse intrinsic pontine glioma 2.46
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 2.44
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 2.43
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 2.43
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 2.42
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 2.41
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 2.35
Gene Expression Profiling of WT and KDM3A Knocked out Cell 2.32
Genome-wide maps of chromatin state and Gene Expression Profiling in HCT116 cells 2.32
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 2.31
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 2.29
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 2.29
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 2.27
Effect of drugs on transcriptomic profiles 2.25
Gene expression profiles of BxPC-3, MiaPaCa-2 and PANC-1 cell lines treated with DMSO and THZ1 respectively 2.25
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 2.24
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 2.22
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 2.22
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 2.2
SETBP1-WT and SETBP1-G870S epigenetic landscapes 2.2
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 2.2
METTL3 and WTAP 2.18
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 2.17
Small-molecule targeting of brachyury transcription factor addiction in chordoma 2.15
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 2.14
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 2.13
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 2.12
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 2.07
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 2.06
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 2.04
RNA binding protein CPEB1 remodels host and viral RNA landscapes [RNA-Seq] 2.03
RNA sequencing of Formalin-Fixed, Paraffin-Embedded Specimens for Gene Expression Quantification and Data Mining 2.03
Glioblastoma stem cells infected by ZIKA virus 2.0
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 1.99
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 1.99
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 1.99
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 1.97
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 1.97
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 1.94
Gene expression activation in CLL mediated by MSCs contact 1.94
Genome-wide discovery of human splicing branchpoints [RNAse] 1.93
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 1.91
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 1.9
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 1.85
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 1.83
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers (RNA-Seq) 1.81
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers 1.81
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 1.8
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. 1.78
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 1.76
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 1.74
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 1.71
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 1.66
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 1.66
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 1.64
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 1.63
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 1.63
Physiologic expression of Sf3b1K700E causes impaired erythropoieses, aberrant splicing, and sensitivity to pharmacologic spliceosome modulation 1.63
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 1.61
Functional significance of the HIV-1 Tat signature amino acid residues 1.6
BET bromodomain inhibitor iBET151 impedes human ILC2 activation and prevents experimental allergic lung inflammation 1.59
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 1.56
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 1.53
CRISPR/Cas9 Screens Reveal Epstein-Barr virus Synthetic Lethal Targets 1.53
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 1.52
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 1.52
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 1.49
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 1.49
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 1.47
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 1.45
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 1.43
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 1.43
Profiling of escape kinetics of viruses subjected to RNAi 1.41
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 1.37
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 1.35
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 1.34
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 1.33
Functional role of SLIT2 and ROBO1 in trophoblasts 1.32
Impact on erythroid progenitor type on erythroid differntiation 1.32
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 1.31
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 1.29
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 1.29
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 1.25
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 1.24
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 1.23
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 1.18
Cell cycle positioning drives heterogeneity within the pluripotent stem cell compartment 1.17
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 1.16
quanTIseq: quantifying immune contexture of human tumors 1.11
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 1.1
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 1.1
RNA-Seq analysis of human neutrophils isolated by different protocols (Polymorphprep and negative selection) and incubated with and without in vitro cytokine stimulation 1.07
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 1.06
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 1.04
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 1.02
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 1.01
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 1.01
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 1.0
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 1.0
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 0.98
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.94
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 0.93
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 0.86
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 0.83
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 0.83
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 0.83
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 0.83
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 0.81
High-resolution comparative analysis of great ape genomes 0.8
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 0.8
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 0.8
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 0.8
Genome-wide detection of DNase I hypersensitive sites in single cells and FFPE tissue samples 0.78
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 0.78
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 0.76
Myc activation coordinates gene transcription and protein translation responses 0.75
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 0.75
K562 polyA RNA-Seq 0.74
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 0.73
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 0.73
Targeted enhancer activation by a subunit of the integrator complex 0.73
naive T cell heterogeneity after neonatal thymectomy 0.72
Gene expression analysis upon mtDNA depletion [RNA-seq] 0.71
Gene expression analysis upon mtDNA depletion 0.71
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 0.69
A20 regulates canonical wnt-signaling through an interaction with RIPK4 0.67
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 0.67
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 0.65
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 0.64
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 0.63
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 0.63
RNA-seq on Enasidenib or DMSO Treated CD71+ Cells from Umbilical Cord Blood (UCB) 0.63
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 0.61
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 0.61
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 0.6
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 0.6
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 0.6
Determining mRNA half-lives on a transcriptome-wide scale 0.58
Transcriptomic analysis of LSD1 0.58
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration 0.57
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 0.53
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 0.53
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 0.53
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 0.53
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 0.53
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 0.51
RNA sequencing reveals transcriptional changes after Hippo signaling activation in podocytes 0.49
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 0.49
RNA-Seq from human ILC transitional populations 0.48
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 0.48
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 0.48
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 0.48
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.48
Transcriptome analysis of diverse cell types infected with human cytomegalovirus 0.45
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 0.44
circNFIB suppresses lymphatic metastasis of pancreatic cancer 0.43
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.42
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 0.41
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 0.4
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 0.39
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 0.39
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 0.37
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 0.34
Energy Metabolism during Anchorage-Independence 0.34
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 0.32
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 0.32
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 0.3
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 0.3
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 0.29
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.28
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.28
KLF6-dependent transcription in renal cancer cells 0.28
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 0.27
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 0.23
Expression data from fresh human embryonic lung epithelial tip and stalk cells and cultured organoids derived from tip and stalk. 0.21
Function and hormonal regulation of GATA3 in human first trimester placentation 0.21
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 0.2
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 0.19
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 0.18
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 0.17
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 0.15
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 0.15
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 0.14
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.12
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 0.12
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 0.11
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 0.09
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 0.09
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.08
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 0.07
The role of m6A/m-RNA methylation in stress response regulation 0.07
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 0.06
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 0.06
Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in Chronic Lymphocytic Leukemia 0.06
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 0.04
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 0.04
MHC Transcriptomic landscape at haplotype-specific resolution 0.03
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 0.03
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 0.01
Subtle asymmetry of gene expression in embryonic and foetal human brains 0.01
Downregulation of LATS kinases alters p53 to promote cell migration 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation